Company Filing History:
Years Active: 2025
Title: Aksana Labokha: Innovator in Immunotherapy
Introduction
Aksana Labokha is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of immunotherapy, particularly through her innovative work on antibodies that target the Inducible T cell Co-Stimulator (ICOS). Her research aims to enhance the immune response in patients, especially in the context of cancer treatment.
Latest Patents
Aksana holds a patent for "Antibodies to ICOS," which focuses on antibodies that bind to ICOS. This invention has therapeutic applications for modulating the ratio between regulatory T cells and effector T cells. The goal is to stimulate the immune system of patients, including potential uses in treating various cancers. Additionally, her work explores combinations of anti-ICOS antibodies with other drugs for immuno-oncology applications.
Career Highlights
Aksana Labokha is currently associated with Kymab Limited, where she continues to advance her research in immunotherapy. Her innovative approach has positioned her as a key figure in the development of new therapeutic strategies aimed at improving patient outcomes in oncology.
Collaborations
Aksana collaborates with talented colleagues, including Nahida Parveen and Jacob Galson, who contribute to her research efforts and help drive forward the mission of Kymab Limited.
Conclusion
Aksana Labokha's work in developing anti-ICOS antibodies represents a significant advancement in immunotherapy, with the potential to transform cancer treatment. Her contributions to the field highlight the importance of innovation in medical research and the ongoing quest for effective therapies.